Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Johnson and Johnson
Dow
Colorcon
Queensland Health
Deloitte
Boehringer Ingelheim
McKinsey
AstraZeneca

Generated: October 18, 2017

DrugPatentWatch Database Preview

IMIPRAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Imipramine Hydrochloride, and what generic Imipramine Hydrochloride alternatives are available?

Imipramine Hydrochloride is a drug marketed by Sandoz, Leading Pharma Llc, Vangard, Watson Labs, Par Pharm, West Ward, Teva, Lupin Ltd, Mallinckrodt Inc, Sun Pharm Inds, Oxford Pharms, Novartis, Lederle, Usl Pharma, and Roxane. and is included in thirty-six NDAs.

The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.

Summary for Tradename: IMIPRAMINE HYDROCHLORIDE

US Patents:0
Applicants:15
NDAs:36
Suppliers / Packagers: see list20
Bulk Api Vendors: see list38
Clinical Trials: see list2,315
Patent Applications: see list740
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMIPRAMINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: IMIPRAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL085877-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL088262-001Oct 21, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe
Roxane
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL083799-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oxford Pharms
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL040751-003Feb 28, 2008RXNoNo► Subscribe► Subscribe► Subscribe
Novartis
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
CONCENTRATE;ORAL086765-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oxford Pharms
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL040751-002Feb 28, 2008RXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL085200-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL084937-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL087846-003May 22, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
IMIPRAMINE HYDROCHLORIDE
imipramine hydrochloride
TABLET;ORAL088276-001Oct 21, 1983ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Cerilliant
McKesson
Express Scripts
QuintilesIMS
Fish and Richardson
Novartis
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot